Search research articles
Contact Us
Filters
Showing results (171-180 of 373) with videos related to
Page
of 38
Sort By:
Molecular Therapy Oncolytics
|
July 31, 2020
PSMA-Directed CAR T Cells Combined with Low-Dose Docetaxel Treatment Induce Tumor Regression in a Prostate Cancer Xenograft Model
Jamal Alzubi, Viviane Dettmer-Monaco, Johannes Kuehle, et al.
Blood
|
September 11, 2014
MiR-146a regulates the TRAF6/TNF-axis in donor T cells during GVHD
Natalie Stickel, Gabriele Prinz, Dietmar Pfeifer, et al.
Nuklearmedizin. Nuclear Medicine
|
April 9, 2024
FDG-PET/CT is a powerful tool to predict and evaluate response to chimeric antigen receptor (CAR) T-cell therapy in Non-Hodgkin-Lymphoma (NHL)
Christoph-Ferdinand Wielenberg, Johannes Christian Fostitsch, Christian Volz, et al.
Annals of Hematology
|
August 3, 2016
Anti-thymocyte globulin-induced hyperbilirubinemia in patients with myelofibrosis undergoing allogeneic hematopoietic cell transplantation
Matyas Ecsedi, Jörg Schmohl, Robert Zeiser, et al.
Bone Marrow Transplantation
|
July 22, 2025
Treatment patterns of extracorporeal photopheresis in steroid-refractory graft versus host disease: A delphi study
Olaf Penack, Andrea Bacigalupo, Eleni Gavriilaki, et al.
The Journal of Experimental Medicine
|
November 10, 2010
Lack of the purinergic receptor P2X(7) results in resistance to contact hypersensitivity
Felix C Weber, Philipp R Esser, Tobias Müller, et al.
Bone Marrow Transplantation
|
June 28, 2020
Comparison of reduced-toxicity conditioning protocols using fludarabine, melphalan combined with thiotepa or carmustine in allogeneic hematopoietic cell transplantation
Jesús Duque-Afonso, Gabriele Ihorst, Miguel Waterhouse, et al.
Transfusion Medicine and Hemotherapy : Offizielles Organ Der Deutschen Gesellschaft Fur Transfusionsmedizin Und Immunhamatologie
|
March 20, 2026
Clinical Development Programme of the Innovative Mesenchymal Stromal Cell Product MSC-FFM/MC0518 for Steroid-Refractory Acute Graft-Versus-Host Disease: Design of 2 Randomised Controlled Trials in Adult and Paediatric Patients
Robert Zeiser, Halvard Bönig, Elena Osswald, et al.
Cancer Research
|
December 17, 2010
CXCL12 mediates immunosuppression in the lymphoma microenvironment after allogeneic transplantation of hematopoietic cells
Christoph Dürr, Dietmar Pfeifer, Rainer Claus, et al.
Blood
|
January 21, 2012
Deficiency of CD73/ecto-5'-nucleotidase in mice enhances acute graft-versus-host disease
Hiroki Tsukamoto, Petya Chernogorova, Korcan Ayata, et al.
Page
of 38
Search research articles
Search
Showing results (171-180 of 373) with videos related to
Sort By:
Page
of 38
Molecular Therapy Oncolytics
|
July 31, 2020
PSMA-Directed CAR T Cells Combined with Low-Dose Docetaxel Treatment Induce Tumor Regression in a Prostate Cancer Xenograft Model
Jamal Alzubi, Viviane Dettmer-Monaco, Johannes Kuehle, et al.
Blood
|
September 11, 2014
MiR-146a regulates the TRAF6/TNF-axis in donor T cells during GVHD
Natalie Stickel, Gabriele Prinz, Dietmar Pfeifer, et al.
Nuklearmedizin. Nuclear Medicine
|
April 9, 2024
FDG-PET/CT is a powerful tool to predict and evaluate response to chimeric antigen receptor (CAR) T-cell therapy in Non-Hodgkin-Lymphoma (NHL)
Christoph-Ferdinand Wielenberg, Johannes Christian Fostitsch, Christian Volz, et al.
Annals of Hematology
|
August 3, 2016
Anti-thymocyte globulin-induced hyperbilirubinemia in patients with myelofibrosis undergoing allogeneic hematopoietic cell transplantation
Matyas Ecsedi, Jörg Schmohl, Robert Zeiser, et al.
Bone Marrow Transplantation
|
July 22, 2025
Treatment patterns of extracorporeal photopheresis in steroid-refractory graft versus host disease: A delphi study
Olaf Penack, Andrea Bacigalupo, Eleni Gavriilaki, et al.
The Journal of Experimental Medicine
|
November 10, 2010
Lack of the purinergic receptor P2X(7) results in resistance to contact hypersensitivity
Felix C Weber, Philipp R Esser, Tobias Müller, et al.
Bone Marrow Transplantation
|
June 28, 2020
Comparison of reduced-toxicity conditioning protocols using fludarabine, melphalan combined with thiotepa or carmustine in allogeneic hematopoietic cell transplantation
Jesús Duque-Afonso, Gabriele Ihorst, Miguel Waterhouse, et al.
Transfusion Medicine and Hemotherapy : Offizielles Organ Der Deutschen Gesellschaft Fur Transfusionsmedizin Und Immunhamatologie
|
March 20, 2026
Clinical Development Programme of the Innovative Mesenchymal Stromal Cell Product MSC-FFM/MC0518 for Steroid-Refractory Acute Graft-Versus-Host Disease: Design of 2 Randomised Controlled Trials in Adult and Paediatric Patients
Robert Zeiser, Halvard Bönig, Elena Osswald, et al.
Cancer Research
|
December 17, 2010
CXCL12 mediates immunosuppression in the lymphoma microenvironment after allogeneic transplantation of hematopoietic cells
Christoph Dürr, Dietmar Pfeifer, Rainer Claus, et al.
Blood
|
January 21, 2012
Deficiency of CD73/ecto-5'-nucleotidase in mice enhances acute graft-versus-host disease
Hiroki Tsukamoto, Petya Chernogorova, Korcan Ayata, et al.
Page
of 38